MENU
+Compare
OCPNF
Stock ticker: OTC
AS OF
Aug 25 closing price
Price
$11.86
Change
-$0.15 (-1.25%)
Capitalization
13.23B

OCPNF stock forecast, quote, news & analysis

Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream... Show more

OCPNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for OCPNF with price predictions
Aug 25, 2025

OCPNF's Indicator enters downward trend

The Aroon Indicator for OCPNF entered a downward trend on July 29, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 142 similar instances where the Aroon Indicator formed such a pattern. In of the 142 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where OCPNF's RSI Oscillator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 25, 2025. You may want to consider a long position or call options on OCPNF as a result. In of 65 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OCPNF just turned positive on July 29, 2025. Looking at past instances where OCPNF's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.688) is normal, around the industry mean (60.144). P/E Ratio (17.000) is within average values for comparable stocks, (38.612). OCPNF's Projected Growth (PEG Ratio) (3.432) is slightly higher than the industry average of (1.728). Dividend Yield (0.012) settles around the average of (0.019) among similar stocks. P/S Ratio (2.008) is also within normal values, averaging (80.118).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OCPNF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCPNF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
published Dividends

OCPNF paid dividends on June 03, 2021

Olympus Corp. OCPNF Stock Dividends
А dividend of $12.00 per share was paid with a record date of June 03, 2021, and an ex-dividend date of March 30, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.67B. The market cap for tickers in the group ranges from 1.86K to 229.03B. ABT holds the highest valuation in this group at 229.03B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 4%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 10%. MCRXF experienced the highest price growth at 200%, while NVNO experienced the biggest fall at -81%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -69%. For the same stocks of the Industry, the average monthly volume growth was -26% and the average quarterly volume growth was -9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 76
Price Growth Rating: 62
SMR Rating: 88
Profit Risk Rating: 92
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
OCPNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
Shinjuku Monolith
Phone
+81 333402111
Employees
36520
Web
http://www.olympus.co.jp